Ana Saborido

Ana Saborido

Auto-generated profile, based on publicly available information

Ana Saborido

Complutense University

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1994 in Biochemical Medicine and Metabolic Biology
Verified
Journal Article
Closed access
MBM.A. Birchmachin
M.A. Birchmachin
HBH.L. Briggs
H.L. Briggs
SASaborido A. A.
Saborido A. A.
LBL.A. Bindoff
L.A. Bindoff
DTD.M. Turnbull
D.M. Turnbull

1 February 2020 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
AUAneta K. Urbanek
Aneta K. Urbanek
AMAleksandra M. Mirończuk
Aleksandra M. Mirończuk
AGAlberto García-Martín
Alberto García-Martín
ASAna Saborido
Ana Saborido
IMIsabel de la Mata
Isabel de la Mata
MAMiguel Arroyo
Miguel Arroyo

1 July 2014 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
RMRicardo Mora-Rodriguez
Ricardo Mora-Rodriguez
JOJ.F. Ortega
J.F. Ortega
NHN. Hamouti
N. Hamouti
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
JGJ. Cañete Garcia-Prieto
J. Cañete Garcia-Prieto
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino

1 December 2003 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
Angel L. PeyAngel L. Pey
Angel L. Pey
ASAna Saborido
Ana Saborido
IBIsabel Blázquez
Isabel Blázquez
JDJerónimo Delgado
Jerónimo Delgado
AMAlicia Megı́as
Alicia Megı́as

1 October 1999 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
Alejandro LuciaAlejandro Lucia
Alejandro Lucia
LSL Serratosa
L Serratosa
ASA Saborido
A Saborido
JPJ Pardo
J Pardo
ABA Boraita
A Boraita
JCJ L Chicharro
J L Chicharro
The purpose of this study was to analyze the short-term effects of a marathon race (Madrid Marathon) on both markers of cardiac damage and echocardiographic parameters in a group of 22 runners (17 male and 5 female; 34 +/- 5 yr; VO2max: 55.7 +/- 9.1 mL x kg(-1) x min(-1) with a wide range of fitness levels. Venous blood samples were collected from each subject 48 h before the race, at race finish, and 6, 24, and 48 h postexercise for the determination of myoglobin, total creatine kinase catalytic activity (total CK), mass concentration of creatine kinase isoenzyme MB (CK-MB mass), and cardiac isoforms of troponin T and I (TnT-c and TnI-c, respectively). In addition, echocardiographic parameters (M-mode two-dimensional and Doppler analysis) indicative of both left ventricular (LV) systolic and diastolic function were obtained three times from each runner: 2-5 d before the race, at race finish, and 24-36 h after exercise. Except in one subject, levels of TnT-c and TnI-c were within normal limits (<0.1 ng x mL(-1)) in all the samples collected before or after the race. Overall LV systolic function was not altered by marathon running. Finally, LV diastolic function was transiently altered after the race since the ratio between peak early and late transmitral filling velocities (E/A) was significantly reduced at race finish (P < 0.01) and returned to resting levels after 24-36 h. Our findings suggest that marathon running does not adversely affect the hearts of healthy individuals independently from their training status.

1 March 2011 in Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
ASAna Saborido
Ana Saborido
ANAlba Naudí
Alba Naudí
MPManuel Portero-Otín
Manuel Portero-Otín
RPReinald Pamplona
Reinald Pamplona
AMAlicia Megías
Alicia Megías
Anabolic androgenic steroids are used in the sport context to enhance muscle mass and strength and to increase muscle fatigue resistance. Since muscle fatigue has been related to oxidative stress caused by an exercise-linked reactive oxygen species (ROS) production, we investigated the potential effects of a treatment with the anabolic androgenic steroid stanozolol against oxidative damage induced on rat skeletal muscle mitochondria by an acute bout of exhaustive exercise. Mitochondrial ROS generation with complex I- and complex II-linked substrates was increased in exercised control rats, whereas it remained unchanged in the steroid-treated animals. Stanozolol treatment markedly reduced the extent of exercise-induced oxidative damage to mitochondrial proteins, as indicated by the lower levels of the specific markers of protein oxidation, glycoxidation, and lipoxidation, and the preservation of the activity of the superoxide-sensitive enzyme aconitase. This effect was not due to an enhancement of antioxidant enzyme activities. Acute exercise provoked changes in mitochondrial membrane fatty acid composition characterized by an increased content in docosahexaenoic acid. In contrast, the postexercise mitochondrial fatty acid composition was not altered in stanozolol-treated rats. Our results suggest that stanozolol protects against acute exercise-induced oxidative stress by reducing mitochondrial ROS production, in association with a preservation of mitochondrial membrane properties.